Cognitive behavioural therapy and quality of life in psychologically distressed patients with amyotrophic lateral sclerosis and their caregivers: Results of a prematurely stopped randomized controlled trial

References

• Simmons Z, Bremer BA, Robbins RA, Walsh SM, Fisher S. Quality of life in ALS depends on factors other than strength and physical function. Neurology. 2000;55:388–92.
   PubMed Web of Science ®Google Scholar
• Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med. 1999;48:1507–15.
   PubMed Web of Science ®Google Scholar
• Averill AJ, Kasarskis EJ, Segerstrom SC. Expressive disclosure to improve well-being in patients with amyotrophic lateral sclerosis: a randomized, controlled trial. Psychol Health. 2013;28:701–13.
   PubMed Web of Science ®Google Scholar
• Chiò A, Gauthier A, Calvo A, Ghiglione P, Mutani R. Caregiver burden and patients’ perception of being a burden in ALS. Neurology. 2005;64:1780–2.
   PubMed Web of Science ®Google Scholar
• Creemers H, Veldink JH, Grupstra H, Nollet F, Beelen A, van den Berg LH. Cluster RCT of case management on patients’ quality of life and caregiver strain in ALS. Neurology. 2014;82:23–31.
   PubMed Web of Science ®Google Scholar
• Goldstein LH, Atkins L, Landau S, Brown R, Leigh PN. Predictors of psychological distress in carers of people with amyotrophic lateral sclerosis: a longitudinal study. Psychol Med. 2006;36:865–75.
   PubMed Web of Science ®Google Scholar
• Gauthier A, Vignola A, Calvo A, Cavallo E, Moglia C, Sellitti L, et al. A longitudinal study on quality of life and depression in ALS patient-caregiver couples. Neurology. 2007;68:923–6.
   PubMed Web of Science ®Google Scholar
• Olsson AG, Markhede I, Strang S, Persson LI. Well-being in patients with amyotrophic lateral sclerosis and their next of kin over time. Acta Neurol Scand. 2010;121:244–50.
   PubMed Web of Science ®Google Scholar
• Murphy V, Felgoise SH, Walsh SM, Simmons Z. Problem solving skills predict quality of life and psychological morbidity in ALS caregivers. Amyotroph Lateral Scler. 2009; 10:147–53.
   PubMed Web of Science ®Google Scholar
• Gielissen MFM, Verhagen S, Witjes F, Bleijenberg G. Effects of cognitive behaviour therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behaviour therapy: a randomized controlled trial. J Clin Oncol. 2006;24:4882–7.
   PubMed Web of Science ®Google Scholar
• Prins JB, Bleijenberg G, Bazelmans E, Elving LD, de Boo TM, Severens JL, et al. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomized controlled trial. Lancet. 2001;357:841–7.
   PubMed Web of Science ®Google Scholar
• Dobson KS, Dozois DJ. Historical and philosophical bases of the cognitive-behavioural therapies. In: Dobson KS, editor. Handbook of Cognitive-Behavioural Therapies. 2nd edn. New York: Guilford Press, 2001.
   Google Scholar
• National Institute for Health and Clinical Excellence. Anxiety: management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. Clinical guidelines CG 22. National Institute for Clinical Excellence: London, 2007.
   Google Scholar
• National Institute for Health and Clinical Excellence. Depression: the treatment and management of depression in adults (update). Clinical guidelines CG 90. National Institute for Clinical Excellence: London, 2009.
   Google Scholar
• van Groenestijn AC, van de Port IG, Schröder CD, Post MW, van den Berg LH, Lindeman E, et al. Effects of aerobic exercise therapy and cognitive behavioural therapy on functioning and quality of life in amyotrophic lateral sclerosis: protocol of the FACTS-2-ALS trial. BMC Neurol. 2011;11:70.
   PubMed Web of Science ®Google Scholar
• Boter H, van Delden JJ, de Haan RJ, Rinkel GJ. A modified informed-consent procedure in which the complete information is given retrospectively: no objection from participating patients. Ned Tijdschr Geneeskd. 2005;149:29–32.
   PubMedGoogle Scholar
• Pocock SJ. Clinical trials. A practical approach. Chichester: Wiley, 1983.
   Google Scholar
• Rabkin JG, Wagner GJ, del Bene M. Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosom Med. 2000;62:271–9.
   PubMed Web of Science ®Google Scholar
• Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey. Manual and Interpretation guide. Boston: The Health Institute, 1993.
   Google Scholar
• Jenkinson C, Hobart J, Chandola T, Fitzpatrick R, Peto V, Swash M; ALS-HPS Steering Group. Amyotrophic Lateral Sclerosis Health Profile Study. Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: tests of data quality, score reliability, response rate and scaling assumptions. J Neurol. 2002;249:178–83.
   Google Scholar
• Jenkinson C, Fitzpatrick R, Brennan C, Bromberg M, Swash M. Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neuron disease: the ALSAQ-40. J Neurol. 1999;246:16–21.
   PubMed Web of Science ®Google Scholar
• Maessen M, Post MW, Maillé R, Lindeman E, Mooij R, Veldink JH, van den Berg LH. Validity of the Dutch version of the Amyotrophic Lateral Sclerosis Assessment Questionnaire, ALSAQ-40, ALSAQ-5. Amyotroph Lateral Scler. 2007;8:96–100.
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.
   PubMed Web of Science ®Google Scholar
• Robinson BC. Validation of a Caregiver Strain Index. J Gerontol. 1983;38:344–8.
   PubMedGoogle Scholar
• Ware JE, Kosinski MA, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME. User’s Manual for the SF-36v2^® Health Survey (2nd edn.).Lincoln, RI: Quality Metric Incorporated, 2007.
   Google Scholar
• Olsson AG, Markhede I, Strang S, Persson LI. Differences in quality of life modalities give rise to needs of individual support in patients with ALS and their next of kin. Palliat Support Care. 2010;8:75–82.
   PubMed Web of Science ®Google Scholar
• Mitsumoto H, Brooks BR, Silani V. Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved? Lancet Neurol. 2014;13:1127–38.
   PubMed Web of Science ®Google Scholar
• Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M; Medical Research Council Guidance. Developing and evaluating complex interventions: the new Medical Research Council guidance. Br Med J. 2008; 337:1655.
   PubMed Web of Science ®Google Scholar